Eli Lilly Says Phase 3 Trial of Tirzepatide Met Primary, Secondary Endpoints

MT NewswiresNov 18 07:55 ET

Weight-loss version of semaglutide launched in the Chinese market! novo-nordisk a/s (NVO.US) unlocks new growth engine.

novo-nordisk a/s launched Wegovy in china, with prices lower than in the usa; this is an important step for the company to intensify its investment in the rapidly growing market in china.

Zhitong Finance23:19 ET

Top Gap Ups and Downs on Monday: TSLA, SMCI, LYFT and More

Moomoo News18:00 ET · Markets

S&P Sees Some Signs of a US Credit Bubble as Spreads Tighten

BNN Bloomberg16:55 ET

Eli Lilly and Co Options Spot-On: On November 18th, 107.32K Contracts Were Traded, With 373.69K Open Interest

Moomoo News16:30 ET

Monday Market Slow but Steady, Trump Buying Crypto Firm | Wall Street Today

Kevin Travers16:21 ET